FindMyKOL
Clinical trialNCT03487588CompletedPhase 4Interventional

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses

SponsorAclaris Therapeutics, Inc.Enrollment41Seborrheic Keratosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Aclaris Investigational Site

    Fort Washington, Pennsylvania, United States

  • Aclaris Investigational Site

    Knoxville, Tennessee, United States

  • Aclaris Investigational Site

    Austin, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

A-101 Topical Solution
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Mar 2018
Primary completion
14 Nov 2018
Completion
14 Nov 2018
Last update posted
2 Oct 2019
Registered enrollment
41
Registry id
NCT03487588

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.